Darmadi, Darmadi, Taufik Sungkar, Cennikon Pakpahan, and Sem Samuel Surja. “An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review”. Acta Medica Academica 53, no. 1 (April 30, 2024): 46–58. Accessed December 2, 2024. https://www.ama.ba/index.php/ama/article/view/564.